Net Income

Wood Partners breaks ground on its third luxury community in Allen's The Farm, a sign of the growing demand for amenity-rich, walkable suburban lifestyles.

A new one-time gene therapy shows it can clear toxic brain plaques in preclinical studies, offering a potential path to halt or even reverse Alzheimer's.

Jet.AI and its partner advance their massive Canadian data center projects, securing natural gas and renewable energy to fuel the future of artificial intelligence.

The firm posted a massive $66M profit, but a $77M non-cash gain and a move to OTC markets urge investors to look beyond the impressive headlines.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.

As traditional income sources falter, Obra Capital's structured products ETF is booming. But do the high yields justify the complex risks involved?

New results from Maxus Mining's Quarry project reveal significant silver, lead, and zinc grades, bolstering BC's role in the critical metals supply chain.

From TikTok sensation to an award-winning brand, a deep dive into how Chlorophyll Water is leading a revolution in clean, functional hydration.

Amid economic uncertainty, M&T Bank's CEO reveals a record $2.88B profit, crediting a focus on local markets and long-term value over risky growth.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

Global esports prize money soared to $270M in 2025, but a new report reveals how Saudi Arabia, China, and the US host nearly half, raising big questions.

CT REIT declared its latest monthly distribution, reinforcing its reputation for reliability. We dig into the numbers and what they mean for investors.

A new compound could make CAR-T cell therapy more durable and less costly, showing promise against both cancer and HIV in groundbreaking new research.

A landmark partnership between Realta Fusion and Kyoto Fusioneering merges American physics with Japanese engineering to accelerate the path to commercial fusion.

The automatic litter box market is booming, but so are user complaints. A new company says its engineered tofu litter is the missing piece for a perfect clean.

With its lead autoimmune drug nearing FDA review and a new $250M in funding, Zenas BioPharma prepares for a major leap from R&D to market.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

Saved from collapse by its own customers, this Chinese designer brand is bringing its powerful 'women supporting women' ethos to the U.S. market.

The electronics manufacturer lands a major contract for C-UAS ground stations, fueling its €1.5B growth plan and bolstering European defense capabilities.

The junior miner's inclusion in the GDXJ and strategic move to Miami aim to boost investor visibility and streamline access to its Colombian gold projects.